46 related articles for article (PubMed ID: 38156840)
1. Accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID 19 pandemic: A tertiary care experience.
Agarwal S; Jaiswal I; Shahi UP; Mandal A; Aggarwal LM; Singh A; Jaiswal A; Yadawa N
J Cancer Res Ther; 2024 Jan; 20(1):404-409. PubMed ID: 38554353
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal Cancer.
Meade S; Gaunt P; Hartley A; Robinson M; Harrop V; Cashmore J; Wagstaff L; Babrah J; Bowden SJ; Mehanna H; Sanghera P
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):366-374. PubMed ID: 29478732
[TBL] [Abstract][Full Text] [Related]
3. Model-Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Vugmeyster Y; Ravula A; Rouits E; Diderichsen PM; Kleijn HJ; Koenig A; Wang X; Schroeder A; Goteti K; Venkatakrishnan K
Clin Pharmacol Ther; 2024 Jan; 115(1):52-61. PubMed ID: 37777832
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy for advanced head and neck cancer - Analysis of a prospective, randomized trial.
Mitra D; Basu S; Deb AR; Rashid MA; Sur PK
Indian J Otolaryngol Head Neck Surg; 2006 Oct; 58(4):360-3. PubMed ID: 23120348
[TBL] [Abstract][Full Text] [Related]
5. Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study.
Roy S; Devleena ; Maji T; Chaudhuri P; Lahiri D; Biswas J
Indian J Med Paediatr Oncol; 2011 Jul; 32(3):133-8. PubMed ID: 22557778
[TBL] [Abstract][Full Text] [Related]
6. Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
Topkan E; Somay E; Selek U
Asian Pac J Cancer Prev; 2024 Feb; 25(2):367-368. PubMed ID: 38415519
[No Abstract] [Full Text] [Related]
7. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
8. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
[TBL] [Abstract][Full Text] [Related]
9. Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
Dwivedi A; Raza MW; Prasad SN; Singh A
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4077-4083. PubMed ID: 38156840
[TBL] [Abstract][Full Text] [Related]
10. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract][Full Text] [Related]
11. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.
Harari PM; Harris J; Kies MS; Myers JN; Jordan RC; Gillison ML; Foote RL; Machtay M; Rotman M; Khuntia D; Straube W; Zhang Q; Ang K
J Clin Oncol; 2014 Aug; 32(23):2486-95. PubMed ID: 25002723
[TBL] [Abstract][Full Text] [Related]
12. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
13. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
14. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
